Grigg A - Search Results

1

Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.

Ong DM, Ashby M, Grigg A, Gard G, Ng ZY, Huang HE, Chong YS, Cheah CY, Devitt B, Chong G, Loh Z, Mo A, Hawkes EA. Ong DM, et al. Among authors: grigg a. Br J Haematol. 2019 Oct;187(1):73-81. doi: 10.1111/bjh.16049. Epub 2019 Jun 17. Br J Haematol. 2019. PMID: 31206608

2

Delayed-onset neutropenia associated with rituximab therapy.

Chaiwatanatorn K, Lee N, Grigg A, Filshie R, Firkin F. Chaiwatanatorn K, et al. Among authors: grigg a. Br J Haematol. 2003 Jun;121(6):913-8. doi: 10.1046/j.1365-2141.2003.04385.x. Br J Haematol. 2003. PMID: 12786803

3

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.

Mitchell PL, Marlton P, Grigg A, Seymour JF, Hertzberg M, Enno A, Herrmann R, Bond R, Arthur C. Mitchell PL, et al. Among authors: grigg a. Leuk Lymphoma. 2008 May;49(5):924-31. doi: 10.1080/10428190802007700. Leuk Lymphoma. 2008. PMID: 18464112 Clinical Trial.

4

Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.

Linch DC, Yung L, Smith P, Maclennan K, Jack A, Hancock B, Cunningham D, Hoskin P, Qian W, Holte H, Boesen AM, Grigg A, Browett P, Trneny M. Linch DC, et al. Among authors: grigg a. Br J Haematol. 2010 Apr;149(2):237-43. doi: 10.1111/j.1365-2141.2010.08081.x. Epub 2010 Mar 1. Br J Haematol. 2010. PMID: 20201949 Clinical Trial.

5

The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults.

Kalff A, Dowsing C, Grigg A. Kalff A, et al. Among authors: grigg a. Br J Haematol. 2010 Jun;149(5):768-74. doi: 10.1111/j.1365-2141.2010.08150.x. Epub 2010 Mar 21. Br J Haematol. 2010. PMID: 20346014

6

Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.

Dickinson M, Hoyt R, Roberts AW, Grigg A, Seymour JF, Prince HM, Szer J, Ritchie D. Dickinson M, et al. Among authors: grigg a. Br J Haematol. 2010 Jul;150(1):39-45. doi: 10.1111/j.1365-2141.2010.08162.x. Epub 2010 May 7. Br J Haematol. 2010. PMID: 20507301 Review.

7

Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.

Ho P, Sherman P, Grigg A. Ho P, et al. Among authors: grigg a. Eur J Haematol. 2012 May;88(5):416-21. doi: 10.1111/j.1600-0609.2012.01763.x. Epub 2012 Feb 27. Eur J Haematol. 2012. PMID: 22296221

8

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma.

Gregory G, Arumugaswamy A, Leung T, Chan KL, Abikhair M, Tam C, Bajel A, Cher L, Grigg A, Ritchie D, Opat S. Gregory G, et al. Among authors: grigg a. Neuro Oncol. 2013 Aug;15(8):1068-73. doi: 10.1093/neuonc/not032. Epub 2013 Mar 15. Neuro Oncol. 2013. PMID: 23502429 Free PMC article.

9

Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.

Lee D, Kalff A, Low M, Gangatharan S, Ho P, Bajel A, Ritchie D, Grigg A, Spencer A. Lee D, et al. Among authors: grigg a. Br J Haematol. 2013 Aug;162(3):371-5. doi: 10.1111/bjh.12404. Epub 2013 May 29. Br J Haematol. 2013. PMID: 23718539

10

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).

Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J. Tran H, et al. Among authors: grigg a. Br J Haematol. 2014 Oct;167(2):243-51. doi: 10.1111/bjh.13029. Epub 2014 Jul 11. Br J Haematol. 2014. PMID: 25041261 Clinical Trial.

11

Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice.

Hawkes EA, Chong G, Grigg A. Hawkes EA, et al. Among authors: grigg a. J Clin Oncol. 2015 Apr 1;33(10):1219-20. doi: 10.1200/JCO.2014.60.0486. Epub 2015 Feb 17. J Clin Oncol. 2015. PMID: 25691672 No abstract available.

12

Programmed cell death-1 inhibition in lymphoma.

Hawkes EA, Grigg A, Chong G. Hawkes EA, et al. Among authors: grigg a. Lancet Oncol. 2015 May;16(5):e234-45. doi: 10.1016/S1470-2045(15)70103-8. Lancet Oncol. 2015. PMID: 25943068 Review.

13

Novel fibrinogen mutations (Aα17Gly→Cys and Aα381Ser→Phe) occurring with a 312Thr→Ala polymorphism: allelic phase assigned by direct mass measurement.

Brennan SO, Laurie AD, Mo A, Grigg A. Brennan SO, et al. Among authors: grigg a. Blood Coagul Fibrinolysis. 2015 Dec;26(8):882-6. doi: 10.1097/MBC.0000000000000316. Blood Coagul Fibrinolysis. 2015. PMID: 26083984

14

Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning.

Lasica M, Taylor E, Bhattacharyya P, Bennett A, Cooke RE, Stern C, Agresta F, Ayton R, Grigg A. Lasica M, et al. Among authors: grigg a. Eur J Haematol. 2016 Oct;97(4):348-52. doi: 10.1111/ejh.12737. Epub 2016 Feb 23. Eur J Haematol. 2016. PMID: 26773518

15

Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.

Jalali A, Ha FJ, Chong G, Grigg A, Mckendrick J, Schwarer AP, Doig R, Hamid A, Hawkes EA. Jalali A, et al. Among authors: grigg a. Ann Hematol. 2016 Apr;95(5):809-16. doi: 10.1007/s00277-016-2611-4. Epub 2016 Feb 15. Ann Hematol. 2016. PMID: 26878861

16

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Rummel M, Kim TM, Aversa F, Brugger W, Capochiani E, Plenteda C, Re F, Trask P, Osborne S, Smith R, Grigg A. Rummel M, et al. Among authors: grigg a. Ann Oncol. 2017 Apr 1;28(4):836-842. doi: 10.1093/annonc/mdw685. Ann Oncol. 2017. PMID: 28031173 Free article. Clinical Trial.

17

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Hawkes EA, Chong G, Grigg A. Hawkes EA, et al. Among authors: grigg a. J Clin Oncol. 2017 Jan 20;35(3):371-372. doi: 10.1200/JCO.2016.68.2047. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095269 No abstract available.

18

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Among authors: grigg a. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.

19

Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome.

Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Mo A, et al. Among authors: grigg a. Intern Med J. 2017 Dec;47(12):1361-1367. doi: 10.1111/imj.13544. Intern Med J. 2017. PMID: 28675622

20

Allogeneic stem cell transplantation as a risk factor for recurrent melanoma.

Stevens H, Raj K, Ashby M, Grigg A. Stevens H, et al. Among authors: grigg a. Leuk Lymphoma. 2018 Jul;59(7):1750-1752. doi: 10.1080/10428194.2017.1393670. Epub 2017 Oct 31. Leuk Lymphoma. 2018. PMID: 29087220 No abstract available.

21

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy.

Estacio O, Loh Z, Baker A, Chong G, Grigg A, Churilov L, Hawkes EA. Estacio O, et al. Among authors: grigg a. Intern Med J. 2018 May;48(5):556-560. doi: 10.1111/imj.13712. Intern Med J. 2018. PMID: 29227565

22

Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.

Minson A, Douglas G, Bilmon I, Grigg A. Minson A, et al. Among authors: grigg a. Br J Haematol. 2019 Mar;184(5):840-844. doi: 10.1111/bjh.15186. Epub 2018 Mar 13. Br J Haematol. 2019. PMID: 29532918 No abstract available.

23

Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study.

Loh Z, Estacio O, Grigg A, Holmes NE, Chong G, Hawkes EA. Loh Z, et al. Among authors: grigg a. Support Care Cancer. 2018 Sep;26(9):3083-3089. doi: 10.1007/s00520-018-4162-9. Epub 2018 Mar 21. Support Care Cancer. 2018. PMID: 29564624

24

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma.

Wight JC, Hawkes EA, Berlangieri SU, Khor R, Grigg AP. Wight JC, et al. Among authors: grigg ap. Leuk Lymphoma. 2018 Nov;59(11):2749-2751. doi: 10.1080/10428194.2018.1452217. Epub 2018 Mar 23. Leuk Lymphoma. 2018. PMID: 29569979 No abstract available.

25

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.

Wight JC, Chong G, Grigg AP, Hawkes EA. Wight JC, et al. Among authors: grigg ap. Blood Rev. 2018 Sep;32(5):400-415. doi: 10.1016/j.blre.2018.03.005. Epub 2018 Mar 26. Blood Rev. 2018. PMID: 29605154 Review.

26

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.

Hawkes EA, Loh Z, Estacio O, Chong G, Ha FJ, Gilbertson M, Grigg A. Hawkes EA, et al. Among authors: grigg a. Br J Cancer. 2018 Aug;119(5):546-550. doi: 10.1038/s41416-018-0183-x. Epub 2018 Jul 23. Br J Cancer. 2018. PMID: 30033446 Free PMC article.

27

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.

Grigg SE, Date P, Loh Z, Estacio O, Johnson DF, Hawkes EA, Grigg A. Grigg SE, et al. Among authors: grigg a. Support Care Cancer. 2019 Apr;27(4):1223-1227. doi: 10.1007/s00520-018-4476-7. Epub 2018 Sep 27. Support Care Cancer. 2019. PMID: 30259115

28

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.

Ansell SM, Minnema MC, Johnson P, Timmerman JM, Armand P, Shipp MA, Rodig SJ, Ligon AH, Roemer MGM, Reddy N, Cohen JB, Assouline S, Poon M, Sharma M, Kato K, Samakoglu S, Sumbul A, Grigg A. Ansell SM, et al. Among authors: grigg a. J Clin Oncol. 2019 Feb 20;37(6):481-489. doi: 10.1200/JCO.18.00766. Epub 2019 Jan 8. J Clin Oncol. 2019. PMID: 30620669 Free PMC article. Clinical Trial.

29

Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression.

Piercey OA, Loh Z, Chan J, Chong G, Grigg A, Cheema S, Gill G, Whybird M, Cushion T, Hawkes EA. Piercey OA, et al. Among authors: grigg a. JCO Oncol Pract. 2020 Nov;16(11):e1315-e1323. doi: 10.1200/JOP.19.00771. Epub 2020 Jun 25. JCO Oncol Pract. 2020. PMID: 32584701

30

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.

Lewis KL, Chin CK, Manos K, Casey J, Hamad N, Crawford J, Ho SJ, Issa S, Grigg A, Wood P, Gandhi MK, Do B, Nastoupil L, Hawkes EA, Cheah CY. Lewis KL, et al. Among authors: grigg a. Br J Haematol. 2021 Mar;192(6):1049-1053. doi: 10.1111/bjh.16946. Epub 2020 Jul 16. Br J Haematol. 2021. PMID: 32677095 Clinical Trial.

31

Genomics analysis of leukaemia predisposition in X-linked agammaglobulinaemia.

Nishimura A, Naruto T, Miyamoto S, Grigg A, Bosco JJ, Hoshino A, Amano K, Iwamoto S, Hirayama M, Migita M, Ohara O, Takagi M, Morio T, van Zelm MC, Kanegane H. Nishimura A, et al. Among authors: grigg a. Br J Haematol. 2021 Jun;193(6):1277-1281. doi: 10.1111/bjh.17459. Epub 2021 Apr 14. Br J Haematol. 2021. PMID: 33855700 No abstract available.

32

Safe administration of obinutuzumab to rituximab-intolerant patients.

Manos K, Grigg A. Manos K, et al. Among authors: grigg a. Leuk Lymphoma. 2021 Dec;62(14):3552-3554. doi: 10.1080/10428194.2021.1961232. Epub 2021 Aug 4. Leuk Lymphoma. 2021. PMID: 34348074 No abstract available.

33

Toxicity associated with high-dose intravenous methotrexate for hematological malignancies.

Wight J, Ku M, Garwood M, Carradice D, Lasica M, Keamy L, Hawkes EA, Grigg A. Wight J, et al. Among authors: grigg a. Leuk Lymphoma. 2022 Oct;63(10):2375-2382. doi: 10.1080/10428194.2022.2074987. Epub 2022 May 16. Leuk Lymphoma. 2022. PMID: 35575146

34

Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.

Manos K, Chong G, Keane C, Lee ST, Smith C, Churilov L, McKendrick J, Renwick W, Blombery P, Burgess M, Nelson NE, Fancourt T, Hawking J, Lin W, Scott AM, Barraclough A, Wight J, Grigg A, Fong CY, Hawkes EA. Manos K, et al. Among authors: grigg a. Leukemia. 2023 May;37(5):1092-1102. doi: 10.1038/s41375-023-01863-7. Epub 2023 Mar 11. Leukemia. 2023. PMID: 36906715 Clinical Trial.

35

All-trans retinoic acid--chemotherapy interactions in acute promyelocytic leukaemia.

Roberts AW, Sheridan WP, Grigg AP. Roberts AW, et al. Among authors: grigg ap. Aust N Z J Med. 1992 Dec;22(6):704. doi: 10.1111/j.1445-5994.1992.tb04879.x. Aust N Z J Med. 1992. PMID: 1489298 No abstract available.

36

Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients.

Lickliter JD, Begley CG, Boyd AW, Szer J, Grigg AP. Lickliter JD, et al. Among authors: grigg ap. Leuk Lymphoma. 1994 Sep;15(1-2):91-7. doi: 10.3109/10428199409051683. Leuk Lymphoma. 1994. PMID: 7532059 Clinical Trial.

37

Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF.

Rasko JE, Basser RL, Boyd J, Mansfield R, O'Malley CJ, Hussein S, Berndt MC, Clarke K, O'Byrne J, Sheridan WP, Grigg AP, Begley CG. Rasko JE, et al. Among authors: grigg ap. Br J Haematol. 1997 Jun;97(4):871-80. doi: 10.1046/j.1365-2141.1997.1212937.x. Br J Haematol. 1997. PMID: 9217191 Clinical Trial.

38

Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity.

O'Flaherty E, Cebon J, Grigg AP. O'Flaherty E, et al. Among authors: grigg ap. Leuk Lymphoma. 1997 Oct;27(3-4):343-9. doi: 10.3109/10428199709059689. Leuk Lymphoma. 1997. PMID: 9402332

39

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia.

Grigg AP, Szer J, Beresford J, Dodds A, Bradstock K, Durrant S, Schwarer AP, Hughes T, Herrmann R, Gibson J, Arthur C, Matthews J. Grigg AP, et al. Br J Haematol. 1999 Nov;107(2):409-18. doi: 10.1046/j.1365-2141.1999.01713.x. Br J Haematol. 1999. PMID: 10583235

40

Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age.

Mileshkin L, Biagi JJ, Mitchell P, Underhill C, Grigg A, Bell R, McKendrick J, Briggs P, Seymour JF, Lillie K, Smith JG, Zeldis JB, Prince HM. Mileshkin L, et al. Among authors: grigg a. Blood. 2003 Jul 1;102(1):69-77. doi: 10.1182/blood-2002-09-2846. Epub 2003 Mar 13. Blood. 2003. PMID: 12637329 Free article. Clinical Trial.

41

Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.

Grigg A, Solal-Celigny P, Hoskin P, Taylor K, McMillan A, Forstpointner R, Bacon P, Renwick J, Hiddemann W; International Study Group. Grigg A, et al. Leuk Lymphoma. 2003 Sep;44(9):1503-8. doi: 10.1080/1042819031000103953. Leuk Lymphoma. 2003. PMID: 14565651 Clinical Trial.

42

The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.

Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM. Ritchie DS, et al. Among authors: grigg ap. Ann Hematol. 2007 Feb;86(2):101-5. doi: 10.1007/s00277-006-0193-2. Epub 2006 Nov 7. Ann Hematol. 2007. PMID: 17089127 Clinical Trial.

43

A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.

Pasricha SR, Grigg A, Catalano J, Leahy M, Underhill C, Arthur C, D'Rozario J, Lowenthal R, Reed K, Spencer A. Pasricha SR, et al. Among authors: grigg a. Cancer. 2008 Dec 1;113(11):3192-8. doi: 10.1002/cncr.23915. Cancer. 2008. PMID: 18932253 Free article. Clinical Trial.

44

Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.

Hoyt R, Ritchie DS, Wirth A, Szer J, Grigg AP. Hoyt R, et al. Among authors: grigg ap. Bone Marrow Transplant. 2010 Sep;45(9):1457-62. doi: 10.1038/bmt.2009.365. Epub 2010 Jan 11. Bone Marrow Transplant. 2010. PMID: 20062098

45

A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.

Hertzberg M, Matthews JP, Stone JM, Dubosq MC, Grigg A, Ellis D, Benson W, Browett P, Horvath N, Januszewicz H, Abdi E, Green M, Bonaventura A, Marlton P, Cannell P, Wolf M; ALLG. Hertzberg M, et al. Among authors: grigg a. Am J Hematol. 2014 May;89(5):536-41. doi: 10.1002/ajh.23684. Epub 2014 Feb 21. Am J Hematol. 2014. PMID: 24481640 Free article. Clinical Trial.

46

The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.

Banerjee A, Mifsud NA, Bird R, Forsyth C, Szer J, Tam C, Kellner S, Grigg A, Motum P, Bentley M, Opat S, Grigoriadis G. Banerjee A, et al. Among authors: grigg a. Br J Haematol. 2015 Feb;168(4):576-82. doi: 10.1111/bjh.13151. Epub 2014 Oct 1. Br J Haematol. 2015. PMID: 25271366

47

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Among authors: grigg a. Lancet Haematol. 2015 Sep;2(9):e357-66. doi: 10.1016/S2352-3026(15)00115-5. Epub 2015 Aug 20. Lancet Haematol. 2015. PMID: 26685769 Clinical Trial.

48

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.

49

Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine.

Prabahran A, Tacey M, Fleming S, Wei A, Tate C, Marlton P, Wight J, Grigg A, Tuckfield A, Szer J, Ritchie D, Chee L. Prabahran A, et al. Among authors: grigg a. Eur J Haematol. 2018 May 2. doi: 10.1111/ejh.13089. Online ahead of print. Eur J Haematol. 2018. PMID: 29719925

50

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.

51

Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.

Sellar RS, Mehra V, Fox TA, Grigg A, Kulasekararaj A, Sarma A, de Lavallade H, McLornan D, Raj K, Mufti GJ, Pagliuca A, Mackinnon S, Chakraverty R, Fielding AK, Carpenter B, Kottaridis PD, Khwaja A, Peggs KS, Thomson KJ, Morris EC, Potter VT. Sellar RS, et al. Among authors: grigg a. Br J Haematol. 2019 Oct;187(1):e20-e24. doi: 10.1111/bjh.16136. Epub 2019 Aug 8. Br J Haematol. 2019. PMID: 31396948 No abstract available.

52

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.

Evens AM, Connors JM, Younes A, Ansell SM, Kim WS, Radford J, Feldman T, Tuscano J, Savage KJ, Oki Y, Grigg A, Pocock C, Dlugosz-Danecka M, Fenton K, Forero-Torres A, Liu R, Jolin H, Gautam A, Gallamini A. Evens AM, et al. Among authors: grigg a. Haematologica. 2022 May 1;107(5):1086-1094. doi: 10.3324/haematol.2021.278438. Haematologica. 2022. PMID: 34162178 Free PMC article.

53

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.

Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K; ELOQUENT-1 investigators. Dimopoulos MA, et al. Lancet Haematol. 2022 Jun;9(6):e403-e414. doi: 10.1016/S2352-3026(22)00103-X. Epub 2022 May 9. Lancet Haematol. 2022. PMID: 35550060 Free article. Clinical Trial.

54

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.

Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD. Talbot SM, et al. Among authors: grigg ap. Ann Oncol. 1999 Aug;10(8):907-14. doi: 10.1023/a:1008353522601. Ann Oncol. 1999. PMID: 10509151 Free article. Clinical Trial.

55

Acute left ventricular failure following melphalan and fludarabine conditioning.

Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP. Ritchie DS, et al. Among authors: grigg ap. Bone Marrow Transplant. 2001 Jul;28(1):101-3. doi: 10.1038/sj.bmt.1703098. Bone Marrow Transplant. 2001. PMID: 11498753

56

Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcoma.

Ritchie DS, Grigg AP, Roberts AW, Rosenthal MA, Fox RM, Szer J. Ritchie DS, et al. Among authors: grigg ap. Intern Med J. 2004 Jul;34(7):431-4. doi: 10.1111/j.1444-0903.2004.00630.x. Intern Med J. 2004. PMID: 15271179 Review. No abstract available.

57

Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.

Grigg AP, Reynolds J, McQuillan A, Juneja SK, Di Iulio J, Hui C, Smith C, Kimber R, Bradstock KF; Australasian Leukaemia and Lymphoma Group. Grigg AP, et al. Leuk Lymphoma. 2005 Mar;46(3):367-75. doi: 10.1080/10428190400013076. Leuk Lymphoma. 2005. PMID: 15621826 Clinical Trial.

58

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review.

Grigg AP, Bashford J, Seymour JF, Shuttleworth P, Norris D, Hertzberg M, Gill D, Waugh M, Saal R, Marlton P. Grigg AP, et al. Leuk Lymphoma. 2005 Jun;46(6):851-60. doi: 10.1080/10428190500052461. Leuk Lymphoma. 2005. PMID: 16019529 Clinical Trial.

59

Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.

Wirth A, Grigg A, Wolf M, Goldstein D, Johnson C, Davis S, Dutu G, Kypreos P, Smith C, Kneebone A, Herzberg M, Joseph D, Catalano J, Roos D, Stone J, Reynolds J. Wirth A, et al. Among authors: grigg a. Leuk Lymphoma. 2011 May;52(5):786-95. doi: 10.3109/10428194.2010.547155. Epub 2011 Feb 14. Leuk Lymphoma. 2011. PMID: 21314490 Clinical Trial.

60

An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trial.

Lickliter JD, Taylor K, Szer J, Grigg A, Arthur C, Hughes TP, Durrant S, Filshie R, Irving I, Seldon M, Ellacott J, Boyd AW, D'Rozario J, Rooney K, Lynch K, Bradstock K; Australasian Leukaemia and Lymphoma Group. Lickliter JD, et al. Among authors: grigg a. Leuk Lymphoma. 2015 Mar;56(3):630-8. doi: 10.3109/10428194.2014.925547. Epub 2014 Aug 4. Leuk Lymphoma. 2015. PMID: 24844361 Clinical Trial.

61

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Teh BW, Teng JC, Urbancic K, Grigg A, Harrison SJ, Worth LJ, Slavin MA, Thursky KA. Teh BW, et al. Among authors: grigg a. Haematologica. 2015 Jan;100(1):e28-31. doi: 10.3324/haematol.2014.114025. Epub 2014 Oct 10. Haematologica. 2015. PMID: 25304609 Free PMC article. No abstract available.

62

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.

Doan TN, Kirkpatrick CM, Walker P, Slavin MA, Ananda-Rajah MR, Morrissey CO, Urbancic KF, Grigg A, Spencer A, Szer J, Seymour JF, Kong DC. Doan TN, et al. Among authors: grigg a. J Antimicrob Chemother. 2016 Feb;71(2):497-505. doi: 10.1093/jac/dkv343. Epub 2015 Oct 30. J Antimicrob Chemother. 2016. PMID: 26518050

63

Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.

Jeong W, Haywood P, Shanmuganathan N, Lindsay J, Urbancic K, Ananda-Rajah MR, Chen SC, Bajel A, Ritchie D, Grigg A, Seymour JF, Peleg AY, Kong DC, Slavin MA. Jeong W, et al. Among authors: grigg a. J Antimicrob Chemother. 2016 Dec;71(12):3540-3547. doi: 10.1093/jac/dkw322. Epub 2016 Aug 11. J Antimicrob Chemother. 2016. PMID: 27521358

64

Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).

Ho PJ, Tay L, Teo J, Marlton P, Grigg A, St Pierre T, Brown G, Badcock CA, Traficante R, Gervasio OL, Bowden DK. Ho PJ, et al. Among authors: grigg a. Eur J Haematol. 2017 Feb;98(2):97-105. doi: 10.1111/ejh.12793. Epub 2016 Sep 20. Eur J Haematol. 2017. PMID: 27537786 Clinical Trial.

65

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.

Grigg A, Dyer MJ, Díaz MG, Dreyling M, Rule S, Lei G, Knapp A, Wassner-Fritsch E, Marlton P. Grigg A, et al. Haematologica. 2017 Apr;102(4):765-772. doi: 10.3324/haematol.2016.152272. Epub 2016 Dec 23. Haematologica. 2017. PMID: 28011903 Free PMC article.

66

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

Bradstock KF, Link E, Di Iulio J, Szer J, Marlton P, Wei AH, Enno A, Schwarer A, Lewis ID, D'Rozario J, Coyle L, Cull G, Campbell P, Leahy MF, Hahn U, Cannell P, Tiley C, Lowenthal RM, Moore J, Cartwright K, Cunningham I, Taper J, Grigg A, Roberts AW, Benson W, Hertzberg M, Deveridge S, Rowlings P, Mills AK, Gill D, Bardy P, Campbell L, Seymour JF; Australasian Leukaemia & Lymphoma Group. Bradstock KF, et al. Among authors: grigg a. J Clin Oncol. 2017 May 20;35(15):1678-1685. doi: 10.1200/JCO.2016.70.6374. Epub 2017 Apr 3. J Clin Oncol. 2017. PMID: 28368672 Clinical Trial.

67

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.

Willcox A, Wong E, Nath C, Janson B, Harrison SJ, Hoyt R, Bajel A, Shaw P, Ritchie D, Grigg A. Willcox A, et al. Among authors: grigg a. Ann Hematol. 2018 Dec;97(12):2509-2518. doi: 10.1007/s00277-018-3447-x. Epub 2018 Jul 26. Ann Hematol. 2018. PMID: 30051172 Clinical Trial.

68

Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation.

Robinson DH, Hughes CFM, Grigg A. Robinson DH, et al. Among authors: grigg a. Leuk Lymphoma. 2020 Oct;61(10):2448-2452. doi: 10.1080/10428194.2020.1768381. Epub 2020 May 30. Leuk Lymphoma. 2020. PMID: 32476517

69

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.

Mir F, Mattiello F, Grigg A, Herold M, Hiddemann W, Marcus R, Seymour JF, Bolen CR, Knapp A, Nielsen T, Casulo C. Mir F, et al. Among authors: grigg a. Am J Hematol. 2020 Dec;95(12):1503-1510. doi: 10.1002/ajh.25973. Epub 2020 Sep 16. Am J Hematol. 2020. PMID: 32815559 Free PMC article. Clinical Trial.

70

Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.

Straus D, Collins G, Walewski J, Zinzani PL, Grigg A, Sureda A, Illes A, Kim TM, Alekseev S, Specht L, Buccheri V, Younes A, Connors J, Forero-Torres A, Fenton K, Gautam A, Purevjal I, Liu R, Gallamini A. Straus D, et al. Among authors: grigg a. Leuk Lymphoma. 2020 Dec;61(12):2931-2938. doi: 10.1080/10428194.2020.1791846. Epub 2020 Aug 25. Leuk Lymphoma. 2020. PMID: 32842815 Free article.

71

The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia.

Rees MJ, Wu S, Mokoonlall M, Dix CHK, Bryant CE, D'Rozario J, Schwarer A, Grigg A, Tiong IS. Rees MJ, et al. Among authors: grigg a. Leuk Lymphoma. 2021 Oct;62(10):2531-2534. doi: 10.1080/10428194.2021.1919666. Epub 2021 Apr 26. Leuk Lymphoma. 2021. PMID: 33899667 No abstract available.

72

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

Rees MJ, Mollee P, Ng JY, Murton A, Gonsalves JF, Panigrahi A, Beer H, Loh J, Nguyen P, Hunt S, Jina H, Wayte R, Sutrave G, Tan J, Abeyakoon C, Chee A, Augustson B, Kalro A, Lee C, Agrawal S, Churilov L, Chua CC, Lim ABM, Zantomio D, Grigg A. Rees MJ, et al. Among authors: grigg a. Bone Marrow Transplant. 2021 Sep;56(9):2152-2159. doi: 10.1038/s41409-021-01300-2. Epub 2021 Apr 28. Bone Marrow Transplant. 2021. PMID: 33911199

73

Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.

Tam CS, Gregory GP, Ku M, Fleming S, Handunnetti SM, Lee D, Walker P, Perkins A, Lew TE, Sirdesai S, Chua CC, Gilbertson M, Lasica M, Anderson MA, Renwick W, Grigg A, Patil S, Opat S, Friebe A, Cooke R, De Boer J, Spencer A, Ritchie D, Agarwal R, Blombery P. Tam CS, et al. Among authors: grigg a. Intern Med J. 2022 Jul;52(7):1286-1287. doi: 10.1111/imj.15851. Intern Med J. 2022. PMID: 35879233 No abstract available.

74

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma.

Cliff ERS, Reynolds G, Grigg A. Cliff ERS, et al. Among authors: grigg a. Clin Hematol Int. 2023 Jun;5(2-3):71-77. doi: 10.1007/s44228-023-00031-z. Epub 2023 Feb 8. Clin Hematol Int. 2023. PMID: 36750525 Free PMC article.

75

2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma.

Grigg AP. Grigg AP. Leuk Lymphoma. 2001 Aug;42(4):797-9. doi: 10.3109/10428190109099342. Leuk Lymphoma. 2001. PMID: 11697510

76

Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation.

Grigg AP, Seymour JF. Grigg AP, et al. Leuk Lymphoma. 2002 Apr;43(4):889-92. doi: 10.1080/10428190290017051. Leuk Lymphoma. 2002. PMID: 12153181

77

The impact of conventional and high-dose therapy for lymphoma on fertility.

Grigg A. Grigg A. Clin Lymphoma. 2004 Sep;5(2):84-8. doi: 10.3816/clm.2004.n.013. Clin Lymphoma. 2004. PMID: 15453922 Review.

78

Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.

Holter Chakrabarty JL, Rubinger M, Le-Rademacher J, Wang HL, Grigg A, Selby GB, Szer J, Rowe JM, Weisdorf DJ, Tallman MS. Holter Chakrabarty JL, et al. Among authors: grigg a. Biol Blood Marrow Transplant. 2014 Jul;20(7):1021-5. doi: 10.1016/j.bbmt.2014.03.025. Epub 2014 Mar 30. Biol Blood Marrow Transplant. 2014. PMID: 24691221 Free PMC article.

79

Is there a role for proton pump inhibitor prophylaxis in haematology patients?

Leitinger E, Hui L, Grigg A. Leitinger E, et al. Among authors: grigg a. Intern Med J. 2019 Jun;49(6):694-701. doi: 10.1111/imj.14241. Intern Med J. 2019. PMID: 30719802 Review.

80

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.

Minson AG, Cummins K, Fox L, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A. Minson AG, et al. Among authors: grigg a. Blood Adv. 2019 Apr 9;3(7):1084-1091. doi: 10.1182/bloodadvances.2018028035. Blood Adv. 2019. PMID: 30944100 Free PMC article.

81

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.

Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Sasadeusz J, et al. Among authors: grigg a. Clin Liver Dis. 2019 Aug;23(3):493-509. doi: 10.1016/j.cld.2019.04.010. Epub 2019 Jun 6. Clin Liver Dis. 2019. PMID: 31266623 Review.

82

New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation.

Yong MK, Gottlieb D, Lindsay J, Kok J, Rawlinson W, Slavin M, Ritchie D, Bajel A, Grigg A. Yong MK, et al. Among authors: grigg a. Intern Med J. 2020 Mar;50(3):277-284. doi: 10.1111/imj.14462. Intern Med J. 2020. PMID: 31403736 Review.

83

Nurse-initiated pre-prescribed antibiotic orders to facilitate prompt and appropriate antibiotic administration in febrile neutropenia.

Walker ST, Grigg S, Kirkpatrick C, Urbancic K, Cohen E, Grigg A, Trubiano J. Walker ST, et al. Among authors: grigg s, grigg a. Support Care Cancer. 2020 Sep;28(9):4337-4343. doi: 10.1007/s00520-019-05290-2. Epub 2020 Jan 7. Support Care Cancer. 2020. PMID: 31912358

84

Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3.

Grigg AP, Gascoyne RD, Phillips GL, Horsman DE. Grigg AP, et al. Br J Haematol. 1993 Jan;83(1):158-65. doi: 10.1111/j.1365-2141.1993.tb04647.x. Br J Haematol. 1993. PMID: 8435325

85

Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders.

Seymour JF, Grigg AP, Szer J, Fox RM. Seymour JF, et al. Among authors: grigg ap. Ann Oncol. 2001 Oct;12(10):1455-60. doi: 10.1023/a:1012551809100. Ann Oncol. 2001. PMID: 11762819 Free article. Clinical Trial.

86

A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation.

Ritchie DS, Szer J, Roberts AW, Shuttleworth P, Grigg AP. Ritchie DS, et al. Among authors: grigg ap. Bone Marrow Transplant. 2002 Nov;30(10):645-50. doi: 10.1038/sj.bmt.1703698. Bone Marrow Transplant. 2002. PMID: 12420202 Clinical Trial.

87

Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma.

Wilson WM, Dua U, Grigg AP, Gandhi MK. Wilson WM, et al. Among authors: grigg ap. Leuk Lymphoma. 2006 May;47(5):871-6. doi: 10.1080/10428190600649562. Leuk Lymphoma. 2006. PMID: 16753872

88

Abbreviated dose rituximab for immune-mediated hematological disorders.

Fairweather H, Tuckfield A, Grigg A. Fairweather H, et al. Among authors: grigg a. Am J Hematol. 2008 Jul;83(7):554-7. doi: 10.1002/ajh.21143. Am J Hematol. 2008. PMID: 18314916 Free article.

89

Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia.

Gill S, Grigg A, Szer J, Ritchie D. Gill S, et al. Among authors: grigg a. Leuk Lymphoma. 2008 May;49(5):896-901. doi: 10.1080/10428190801975550. Leuk Lymphoma. 2008. PMID: 18464108

90

The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.

Murphy NM, Diviney M, Szer J, Bardy P, Grigg A, Hoyt R, King-Kallimanis B, Holdsworth R, McCluskey J, Tait BD. Murphy NM, et al. Among authors: grigg a. Biol Blood Marrow Transplant. 2012 May;18(5):722-30. doi: 10.1016/j.bbmt.2011.09.001. Epub 2011 Sep 14. Biol Blood Marrow Transplant. 2012. PMID: 21920473 Free article.

91

Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.

Chua CC, Lim HY, Chai KL, Ong J, Sim S, Wood C, Dickinson M, Campbell P, Hempton J, King H, Dowsing C, Bergin K, Muir S, Gibbs S, Grigg A. Chua CC, et al. Among authors: grigg a. Bone Marrow Transplant. 2018 Sep;53(9):1116-1123. doi: 10.1038/s41409-018-0152-2. Epub 2018 Mar 9. Bone Marrow Transplant. 2018. PMID: 29523889

92

Cerebral toxoplasmosis in a patient with prolonged CD4 lymphopenia post autologous hemopoietic stem cell transplant.

van Mourik A, Grigg A. van Mourik A, et al. Among authors: grigg a. Leuk Lymphoma. 2019 Feb;60(2):544-546. doi: 10.1080/10428194.2018.1485906. Epub 2018 Nov 8. Leuk Lymphoma. 2019. PMID: 30407076 No abstract available.

93

The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.

Lasica M, Willcox A, Burbury K, Ross DM, Branford S, Butler J, Filshie R, Januszewicz H, Joske D, Mills A, Simpson D, Tam C, Taylor K, Watson AM, Wolf M, Grigg A. Lasica M, et al. Among authors: grigg a. Leuk Lymphoma. 2019 Jul;60(7):1796-1802. doi: 10.1080/10428194.2018.1551533. Epub 2019 Jan 11. Leuk Lymphoma. 2019. PMID: 30632843

94

Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia.

van Zelm MC, Pumar M, Shuttleworth P, Aui PM, Smart JM, Grigg A, Bosco JJ. van Zelm MC, et al. Among authors: grigg a. Front Immunol. 2019 Apr 26;10:895. doi: 10.3389/fimmu.2019.00895. eCollection 2019. Front Immunol. 2019. PMID: 31105705 Free PMC article.

95

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.

Sasadeusz J, Grigg A, Hughes PD, Lim SL, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Sasadeusz J, et al. Among authors: grigg a. Clin Liver Dis. 2019 Aug;23(3):511-519. doi: 10.1016/j.cld.2019.04.011. Epub 2019 Jun 6. Clin Liver Dis. 2019. PMID: 31266624 Review.

96

Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Wong E, Davis J, Koldej R, Szer J, Grigg A, Ritchie D. Wong E, et al. Among authors: grigg a. Leuk Lymphoma. 2020 Jan;61(1):185-188. doi: 10.1080/10428194.2019.1648803. Epub 2019 Aug 7. Leuk Lymphoma. 2020. PMID: 31389281 No abstract available.

97

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML.

Schwarer AP, Butler J, Jackson K, Beligaswatte A, Martin L, Kennedy G, Daniela Z, Lewis I, Hiwase D, Wight J, He S, Grigg A, Morris K, Mollee P, Marlton P. Schwarer AP, et al. Among authors: grigg a. Hemasphere. 2018 Nov 28;2(6):e158. doi: 10.1097/HS9.0000000000000158. eCollection 2018 Dec. Hemasphere. 2018. PMID: 31723796 Free PMC article.

98

Treatment practice and outcomes in FLT3-mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals.

Chua CC, Grigg A, Singh J, Droogleever MP, Zhang L, Lim A, Fong CY, Ting SB, Schwarer A, Tiong IS, Wei AH. Chua CC, et al. Among authors: grigg a. Leuk Lymphoma. 2020 Apr;61(4):848-854. doi: 10.1080/10428194.2019.1691192. Epub 2019 Nov 21. Leuk Lymphoma. 2020. PMID: 31752581

99

Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas.

Loo S, Lim A, Lee ST, Grigg A. Loo S, et al. Among authors: grigg a. Clin Lymphoma Myeloma Leuk. 2023 Mar;23(3):e190-e194. doi: 10.1016/j.clml.2022.11.010. Epub 2022 Nov 25. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36707275

100

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Among authors: grigg ap. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters